[Incidence of post-thrombotic syndrome following systemic fibrinolysis of deep venous thrombosis].
Obernosterer
A
A
Med. Univ., Abeteilung für Angiologie, Klinik Graz.
Decrinis
M
M
Pilger
E
E
Lafer
M
M
Pieber
D
D
Stark
G
G
Aschauer
M
M
D005500:Follow-Up Studies; D006801:Humans; D008134:Long-Term Care; D010690:Phlebography; D011186:Postphlebitic Syndrome / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D013924:Thrombophlebitis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects*
D014568:Urokinase-Type Plasminogen Activator
Inzidenz eines postthrombotischen Syndroms nach systemischer Fibrinolyse von tiefen Venenthrombosen.